RITE AID

Those recognized this week were chosen by a panel of judges from more than 15,000 customer-submitted entries in the annual program, which was conducted last October for American Pharmacists month.

As retail pharmacy competition has heated up, Rite Aid management shifted its focus to more profitable business segments, namely drug store prescriptions and e-commerce, as well as its pharmacy benefit manager EnvisionRxOptions.

Rite Aid is making the Measles-Mumps-Rubella, or MMR, vaccine available upon request at pharmacies across California, including Los Angeles.

The company this week announced the appointment of Elizabeth “Busy” Burr and Katherine Quinn to the board. They mark the fourth and fifth independent directors added to the nine-person board in the past year.

Despite delivering a record number of immunizations, continued same-store pharmacy sales and script count increases and solid growth within its EnvisionRxOptions segment, Rite Aid swung to a loss for its fourth quarter and fiscal year 2019.

As it looks to improve front-end performance, Rite Aid is bringing CBD products to Oregon and Washington, doing away with e-cigarettes and focusing on own-brand penetration.

The Rite Aid Foundation is bringing its Prescription Drug Safety Program to schools in Portland, Ore., in an attempt to curb drug abuse and misuse among teens.

At a special meeting on Thursday, shareholder voted 78% in favor of the reverse split, the company said.